baber/WOPTO huggingface dataset:
Patent AU-5279098-A (AU)
Title: A drug preparation for oral administration
Inventor: YOSHII HARUO
IPC: A61P37/00
Filed: 1998-01-29
Abstract: To offer a drug preparation for oral administration containing histamine-added immunoglobulin as an effective component. This invention relates a drug preparation for oral administration containing histamine-added immunoglobulin as an effective component. As same as usual hypodermic injection, the drug preparation for oral administration of the present invention is useful as a pharmaceutical agent for prevention or treatment of allergic diseases such as bronchial asthma, allergic rhinitis, vasomotor rhinitis, urticaria, chronic eczema and atopic dermatitis; autoimmune diseases such as multiple sclerosis, chronic rheumatoid arthritis and systemic lupus erythematodes; various immunodeficiency syndromes; and also eosinophilia or various inflammatory diseases caused by infectious diseases, parasitic diseases, diseases of respiratory organs, autoimmune diseases, malignant tumor, etc. The drug preparation which can be administerd orally like as the preparation of the present invention can be taken by the patients easier than an injectable preparation. Therefore, the drug preparation for oral administration of the present invention is practical and highly useful actually.
Patent AU-5325900-A (AU)
Title: Controlled diffusion analysis
Inventor: HARP DANIAL L
IPC: G01N31/22
Filed: 2000-06-02
Abstract: A method is described for determining the presence of a volatile component in a test sample. The method involves use of two separate vessels, one of which is capable of being placed wholly within the other vessel. The test sample is placed in the larger vessel, and an indicator solution is placed in the smaller, inner vessel. Then a gas-tight closure is placed on the top of the outer, larger vessel. The assembly is heated to an elevated temperature, whereby the volatile target analyte which is released from the test sample transfers to the inner vessel and is absorbed by the indicator solution. The indicator solution can be analyzed by means of a calorimeter, spectrophotometer, etc.
Patent AU-5347299-A (AU)
Title: Modified starch film compositions
Inventor: SCOTT ROBERT ANTHONY
IPC: A61K9/24
Filed: 1999-08-11
Abstract: The invention concerns compositions from modified starches, such as starch ethers or oxidized starch, more particularly hydroxpropylated starch (HPS) or hydroxylethylated starch (HES) for the use in pharmaceutical, veterinary, food, cosmetic or other products like films for wrapping food, aspics or jellies, preferably for predosed formulations like soft or hard capsules. The hard capsules obtained by the present invention with a conventional dipping molding process are similar to hard gelatine capsules (HGC).
Patent AU-5421299-A (AU)
Title: Substituted cinnamic acids and cinnamic acid esters
Inventor: LANGE WALTER
IPC: C07C51/353
Filed: 1999-08-09
Abstract: The invention relates to substituted cinnamic acids and cinnamic acid esters of formula (I), wherein X represents F, Cl or J and R1 and R2 are the same or different and represent hydrogen, an optionally substituted C1-C10-alkyl radical or an optionally substituted benzyl radical. Substituted indanone carboxylic acid esters are produced using said substituted cinnamic acid and cinnamic acid ester in a technically simple and non-dangerous manner as far as safety is concerned.
Patent AU-5482896-A (AU)
Title: Fusion protein delivery system and uses thereof
Inventor: KAPPES JOHN CHRISTOPHER
IPC: A61K47/48
Filed: 1996-04-12
Abstract: The present invention provides a composition of matter, comprising: DNA encoding a viral Vpx protein fused to DNA encoding a protein. In another embodiment of the present invention, there is provided a composition of matter, comprising: DNA encoding a viral Vpr protein fused to DNA encoding a protein. The present invention further provides DNA, vectors and methods for expressing a lentiviral pol gene in trans, independent of the lentiviral gag-pol. A gene transduction element is optionally delivered to a lentiviral vector according to the present invention. Also provided are various methods of delivering a virus inhibitory molecule to a target in an animal. Further provided is a pharmaceutical composition.
Patent AU-5717594-A (AU)
Title: Pressure vessel
Inventor: WILLIAMS RICHARD T
IPC: B01D35/30
Filed: 1993-07-26
Abstract: A pressure vessel for holding a cartridge, loose media, and the like for conditioning and/or purifying fluid, comprises a cover having a top wall and a side wall extending downwardly therefrom, the side wall having an inner surface, a bowl positioned below the cover and having a bottom wall and a side wall extending upwardly therefrom the side wall having an outer surface, sealing device between the cover and the bowl for sealing between the cover and the bowl, and securing device for securing the cover to the bowl, the securing device including a track comprising a first groove formed in the inner surface of the side wall of the cover and a second groove formed in the outer surface of the side wall of the bowl and being aligned with the first groove, an opening formed in the cover for providing an entrance to the track, and a flexible shear rod received in said track.
Patent AU-5833086-A (AU)
Title: Device for connection between very high intensity electrolysis cells for the production of aluminium comprising a supply circuit and an independent circuit for correcting the magnetic field
Inventor: CHAFFY JOSEPH
IPC: C25C3/16
Filed: 1986-06-04
Abstract: The invention relates to a circuit for electrical connection between two successive cells of a series or row, designed for the production of aluminium by electrolysis of alumina dissolved in molten cryolite by the Hall-Heroult process at an intensity of at least 150 kA and possibly attaining from 500 to 600 kA. The circuit for the electrical supply of the cells comprises, in addition to the circuit 8 for the supply of electrolysis current, a distinct circuit 17 for correcting and balancing the magnetic fields which is formed by conductors which are substantially parallel to the axis of the series and are traversed by a direct current in the same direction as the electrolysis current which creates, in the cells, a vertical correcting magnetic field directed downwards close to the left-hand heads of the cells and directed upwards close to the right-hand heads of the cells. The total current J2 traversing the magnetic correcting circuit is at most equal to the electrolysis current J1 and is preferably between 4 and 80% of J1.
Patent AU-5864400-A (AU)
Title: A heater and a grid for refrigerator defrosting
Inventor: SON MEHMET ALI
IPC: F25D21/00
Filed: 2000-06-05
Abstract: A perforated (6) grid (2) is used to avoid the blocking  of the intermediate division and the water drainage canal (5) by the snow and ice pieces that fall into the water drainage pool (4) in large masses during the defrosting of the evaporator of a two-door, "No-Frost" refrigerator having freezer and fresh food compartments and to melt these masses by means of the switched-in heaters (1). The grid (2) is made of a rectangular and preferably metallic sheet iron piece. At the bottom of the grid (2) perforations (6) are arranged with a certain distance from each other and in any desired number and form. Furthermore, the lowest part of the evaporator (3) heater (1) is seated on the grid (2) base and the heater (1) is mounted by means of the detents (7) formed on the grid (2), in such a manner that it will be in contact with the bottom of the grid (2).
Patent AU-5882396-A (AU)
Title: Automated refuelling system
Inventor: ANDERSON SCOTT ROBERT
IPC: B67D7/54
Filed: 1996-05-29
Abstract: A refuelling system is provided, the system comprising: a seal cylinder defining the outside surface of an axial vapor recovery volume within the seal cylinder having a first end and a second end; a first flexible conduit to supply fuel to within the seal cylinder through the first end; a movable seal piston within the seal cylinder connected to the first flexible conduit, the seal piston effective to isolate a vapor recovery volume within the seal cylinder from the atmosphere surrounding the flexible fuel conduit; a fuel insert tube connected to the seal piston and extending through at least a portion of the vapor recovery volume; a boot seal attached to the seal cylinder at the second end of the axial vapor recovery volume, the boot seal effective to seal with a fuel tank inlet nozzle; and a device to move the seal piston laterally through the seal cylinder and thereby extending the second flexible conduit through the second end of the axial vapor recovery volume and into a fuel tank inlet nozzle when the boot seal is mated to the fuel tank inlet nozzle.
Patent AU-5936099-A (AU)
Title: Carrier strip for fastening elements and a magazine with the carrier strip
Inventor: DAUBINGER GERD
IPC: F16B27/00
Filed: 1999-11-11
Abstract: Fixture components, such as nails and screws, are located in a belt-type magazine which feeds them to an apparatus for driving them into a base. The magazine has several accommodation bodies (1) which are ring-shaped and each have an accommodation aperture (2). The bodies are arranged behind one another and are interconnected. Each accommodation body receives and guides a fixture component.  Each two adjacent accommodation bodies are displaced in relation to each other in a direction running parallel to the longitudinal axis of the accommodation aperture.
Patent AU-5970900-A (AU)
Title: Method for producing an injectable medicament preparation
Inventor: KRATZ FELIX
IPC: A61K47/48
Filed: 2000-06-07
Abstract: Production of an injectable pharmaceutical composition comprises dissolving a drug derivative (I) in an injectable carrier liquid, where (I) comprises a drug linked to a protein-binding group via a spacer and where the spacer or the linkage between the drug and the spacer is pH-dependently or enzymatically cleavable in vivo to release the drug. An independent claim is also included for a drug derivative of type (I) in which the drug is not a cytostatic agent.
Patent AU-6090196-A (AU)
Title: Soft gelatin capsules containing particulate material
Inventor: TANNER KEITH E
IPC: A61K9/48
Filed: 1996-06-06
Abstract: Disclosed are suspensions suitable for encapsulation in gelatin capsules, comprising a solid phase consisting of solid particles having a mean diameter of at least about 149 mum, and a liquid phase capable of suspending the solid phase, the suspension having a predetermined rheology at a temperature suitable for encapsulation into gelatin capsules.
Patent AU-6094286-A (AU)
Title: Container closure made of plastic
Inventor: DUBACH WERNER F
IPC: B65D47/36
Filed: 1986-08-06
Abstract: A container closure attachable directly or indirectly to a container neck sealed by means of a pierceable film seal. The provision of a film seal covering the container neck guarantees the user that the contents of the container are authentic and original as supplied by the manufacturer. The film seal is pierced as the closure is adjusted from an intact to an access position on the container neck. In the upper intact position, a safety band remains intact. The closure can be adjusted to the lower access position only after the safety band has been removed, and the film seal is pierced as the closure is adjusted to the lower access position. Ratchet-like serrations may be provided on the inner side of the safety band engaging the container, thus making it impossible to unscrew a screw-type closure without removing the safety band. The safety band may be provided on a separate intermediate piece which may be snap-fitted or screwed onto the container neck. Opening means for piercing the film seal may be provided on the intermediate piece.
Patent AU-6225894-A (AU)
Title: Compounds having selectivity for retinoid x receptors
Inventor: BOEHM MARCUS F
IPC: C07D333/38
Filed: 1993-10-22
Abstract: Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
Patent AU-6285694-A (AU)
Title: Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
Inventor: CHEDID LOUIS
IPC: A61P35/00
Filed: 1994-03-21
Abstract: PCT No. PCT/FR94/00307 Sec. 371 Date Nov. 13, 1995 Sec. 102(e) Date Nov. 13, 1995 PCT Filed Mar. 21, 1994 PCT Pub. No. WO94/21275 PCT Pub. Date Sep. 29, 1994A therapeutical composition for use in humans, comprising a combination of at least one natural or recombinant and preferably human cytokine with at least one muramyl peptide selected from those which, when administered in vivo together with an interferon, also induce an increased in vivo production of an interleukin-1 receptor antagonist IL-1 RA, but preferably do not induce any increase in TNF, IL-8 and IL-1 cytokines. Said composition is useful for antiviral and antitumoral therapies and/or for promoting restoration of the haematopoietic system, particularly in individuals with a weakened immune system.
Patent AU-6373394-A (AU)
Title: Process for separating mixtures of solids of different density, separating liquid and device for implementing the process
Inventor: PAGENKOPF INGEBORG
IPC: B03B5/36
Filed: 1994-03-17
Abstract: PCT No. PCT/DE94/00313 Sec. 371 Date Aug. 9, 1995 Sec. 102(e) Date Aug. 9, 1995 PCT Filed Mar. 17, 1994 PCT Pub. No. WO94/21382 PCT Pub. Date Sep. 29, 1994A process for separating mixtures of solids of different density, uses a separating liquid and a device for implementing the process. The process is especially suitable for the analysis and technical preparation of waste plastics, glass and electrical scrap. In the process, a reduced mixture of solids with a particle size of 0.1 to 80 mm are brought successively into contact with solutions of separating liquids of differing density in steps of 0.005 to 0.1 g/cm3 within a selected range from that between 0.8 and 2.9 g/cm3 and the floating or sinking solid components are separated after each step. The separating liquid in the density range between 1 and 2.9 is preferably an aqueous solution of an alkali metal salt or an alkaline earth metal salt of metatungstate with a concentration in the range 1 to 80 weight % and an oxidant selected from the chromate, dichromate, permanganate, nitrate, peracid and perester group with a concentration of 0.05 to 0.5 weight %.
Patent AU-6576990-A (AU)
Title: A method of producing a gaseous, hydrogen peroxide-containing sterilisation fluid
Inventor: ANDERSSON JAN
IPC: A23L3/3445
Filed: 1990-11-05
Abstract: A method of producing a gaseous, hydrogen peroxide-containing sterilisation fluid displaying good, uniform sterilisation properties, by vaporisation of liqueform hydrogen peroxide which is injected intermittently in finely-divided form into an air current serving as vaporisation agent which is kept at a constant or but insignificantly varying elevated vaporisation temperature. The even vaporisation temperature of the air current is ensured in that the air, prior to the vaporisation, is heated by heat exchange with a heating element (11) of large mass (thermal capacity) and large heat exchange surface area which is kept at the de- sired elevated temperature by regulated energy supply to the heating element and which, during breaks in vaporisation between the intermittent injection of the liqueform hydrogen peroxide, is heated with the aid of heat stored in the heating element.
Patent AU-6812190-A (AU)
Title: Process and reagent for the determination of the ionic strength or of the specific weight of aqueous liquids
Inventor: MANGOLD DIETER
IPC: G01N33/52
Filed: 1990-12-17
Abstract: The present invention relates to a process for the determination of the ionic strength or of the specific gravity of an aqueous fluid by mixing the fluid with a suitable reagent, determining the pH in the fluid and evaluating, characterised in that the reagent contains at least one pH buffer substance but no polyelectrolyte polymer or at least one pH buffer substance and/or at least one complexing agent, and to the reagent suitable therefor.
Patent AU-6831696-A (AU)
Title: Apparatus for use as an educational toy
Inventor: RIVAZ ANTHONY CHEVALLEY DE
IPC: G09B23/18
Filed: 1996-08-30
Abstract: Apparatus for use as an educational toy, which apparatus comprises a plurality of blocks (2), each block (2) being an electronic block (2) having at least one input (4) and/or at least one output (6), and the blocks (2) being interconnectable whereby different blocks (2) are able to perform different electronic functions and are able to be assembled in an order chosen by the user to convert at least one input signal into at least one predetermined output signal.
Patent AU-6836494-A (AU)
Title: Method for detecting a target nucleic acid
Inventor: WANG CHANG-NING J
IPC: C07H21/04
Filed: 1994-05-23
Abstract: A method for detecting a target nucleic acid, which method includes the steps (i) amplifying the target nucleic acid to obtain an amplification product using a polymerase, a first primer with or without a segment noncontiguous to a first priming sequence, and a second primer with or without a segment noncontiguous to a second priming sequence in the presence of an oligonucleotide which is incapable of acting as a primer for the polymerase, wherein the oligonucleotide has at least 5 consecutive nucleotides fully complementary to at least 5 consecutive nucleotides of the first primer; and (ii) detecting the presence of the target nucleic acid by monitoring amplification thereof. In particular, the figure illustrates the method wherein the primer contains a segment noncontiguous to its priming sequence.
Patent AU-7072694-A (AU)
Title: Substituted aryl-keto-enolic heterocycles
Inventor: BACHMANN JURGEN
IPC: C07D487/04
Filed: 1994-06-22
Abstract: PCT No. PCT/EP94/02042 Sec. 371 Date May 13, 1996 Sec. 102(e) Date May 13, 1996 PCT Filed Jun. 22, 1994 PCT Pub. No. WO95/01971 PCT Pub. Date Jan. 19, 1995The aryl-keto-enolic heterocycles according to the invention have the formula (I), in which Het stands for a heterocyclic group from the series (a), (b) or (c), and X, Y, Z, n, A, B, E, L and M have the meanings given in the description. The compounds having the formula (I) are pesticides, in particular acaricides, insecticides, fungicides and herbicides. Also disclosed is their preparation. MAGE>  (c)
Patent AU-7099094-A (AU)
Title: Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
Inventor: DEAN RICHARD T
IPC: A61K38/31
Filed: 1994-06-03
Abstract: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (<sup>186</sup>Re) and rhenium-188 (<sup>188</sup>Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
Patent AU-7116698-A (AU)
Title: A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
Inventor: BEHAN DOMINIC P
IPC: C07K14/72
Filed: 1998-04-14
Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity.
Patent AU-7285194-A (AU)
Title: biodegradable textile support, in weft knit, for thermo-bonding interlining
Inventor: GROHENS PIERRE
IPC: D04B21/14
Filed: 1994-09-06
Abstract: The invention relates to a process for producing a twist directly from fibre material, in that, by means of at least two spinning assemblies (R1, R2) arranged adjacent to one another, individual spun threads (F1, F2) are made and are first brought together in a hollow shaft (11), so as to run through this together in a first thread running direction, and thereafter are guided out of the hollow shaft (11) in a predominantly radial direction, in order then, in accordance with the two-for-one principle, to form and run through, in opposition to the first running direction, a thread balloon rotating about the spinning assemblies and to be fed through a winding assembly through a centring point (37) located in the extension of the hollow shaft, opened fibre material being fed to each spinning assembly through the enveloping surface defined by the thread balloon, and to a device suitable for carrying out this process. <IMAGE>
Patent AU-7302281-A (AU)
Title: Immersion probe for liquid metals
Inventor: BOLLEN T
IPC: G01K1/10
Filed: 1981-07-14
Abstract: Immersion measuring probe for use in liquid metals of the type consisting of a measuring head (2) carrying at least one measuring element (4) and being fixed to an extremity of a tube (1) which is intended for being slid onto a supporting lance, characterized in that the probe shows at least one projection (7, 8, 9) made of a heat-resistant material which at the side to be immersed reaches farther than the measuring element (4), the said material having a density not exceeding about 2.5 g/cm3.
Patent AU-7424687-A (AU)
Title: Effluent treatment
IPC: C02F1/46
Filed: 1987-06-15
Abstract: A method of treating an organic material such as textile fibres with an alkali metal hydroxide solution including the steps of:   (i) contacting the organic material with the hydroxide solution to produce an effluent comprising an alkali metal hydroxide solution which contains multivalent ions and soluble and insoluble organic and inorganic matter; (ii) reducing the pH of the effluent to a value in the range 7 to 9 by contacting with an acid gas; (iii) filtering the solution from step (ii) to remove suspended insoluble matter having a size greater than 0,1 microns. (iv) filtering the filtrate from step (iii) to remove multivalent ions and organic matter having a molecular mass greater than about 300 daltons; (v) providing an electrochemical cell in which an anode compartment is separated from a cathode compartment by a cation selective membrane; (vi) passing the filtrate from step (iv) into the anode compartment of the electrochemical cell; (vii) passing an electrical current through the cell causing alkali metal ions to pass through the cation selective membrane and alkali metal hydroxide to be produced in the cathode compartment and the acid gas to be produced in the anode compartment;   (viii) returning the alkali metal hydroxide to step (i); and (ix) using the acid gas produced in the cathode compartment for reducing the pH of the effluent in step (ii).
Patent AU-7578194-A (AU)
Title: Biosensor for measuring changes in viscosity and/or density
Inventor: GRZEGORZEWSKI ANDRZEJ
IPC: G01N33/543
Filed: 1994-10-12
Abstract: Biosensor (10) for measuring changes of viscosity and/or density of a fluid to be examined, for example for measuring coagulation of blood or for detecting antigen-antibody reactions. According to the invention, the biosensor (10) is designed as a disposable article, and the reaction component is placed inside a measuring chamber (7) in the vicinity of the measuring surface of the piezoelectric element (8), but not touching the latter. <IMAGE>